Assessing eukaryotic initiation factor 4F subunit essentiality by CRISPR-induced gene ablation in the mouse

[1]  R. Cencic,et al.  RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes , 2020, Nucleic acids research.

[2]  J. Pelletier,et al.  Modulation of RNA Condensation by the DEAD-Box Protein eIF4A , 2020, Cell.

[3]  J. L. Le Quesne,et al.  eIF4A2 drives repression of translation at initiation by Ccr4-Not through purine-rich motifs in the 5′UTR , 2019, Genome Biology.

[4]  N. Sonenberg,et al.  The Organizing Principles of Eukaryotic Ribosome Recruitment. , 2019, Annual review of biochemistry.

[5]  N. Sonenberg,et al.  Translational Control in Cancer. , 2018, Cold Spring Harbor perspectives in biology.

[6]  Y. Fujita,et al.  Competition between translation initiation factor eIF5 and its mimic protein 5MP determines non-AUG initiation rate genome-wide , 2017, Nucleic acids research.

[7]  Antoine de Weck,et al.  Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening , 2017, Cell.

[8]  Jianjun Hu,et al.  Nuclear localization of EIF4G3 suggests a role for the XY body in translational regulation during spermatogenesis in mice† , 2017, Biology of Reproduction.

[9]  S. Yamanaka,et al.  Nat1 promotes translation of specific proteins that induce differentiation of mouse embryonic stem cells , 2016, Proceedings of the National Academy of Sciences.

[10]  R. E. Luna,et al.  Overexpression of eIF5 or its protein mimic 5MP perturbs eIF2 function and induces ATF4 translation through delayed re-initiation , 2016, Nucleic acids research.

[11]  J. Pelletier,et al.  eIF4AII is dispensable for miRNA-mediated gene silencing , 2015, RNA.

[12]  T. Tokuyasu,et al.  Differential Requirements for eIF4E Dose in Normal Development and Cancer , 2015, Cell.

[13]  P. Ivanov,et al.  Stress granules, P-bodies and cancer. , 2015, Biochimica et biophysica acta.

[14]  J. Pelletier,et al.  Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma , 2014, Proceedings of the National Academy of Sciences.

[15]  Susan J. Brown,et al.  Essential role of eIF5-mimic protein in animal development is linked to control of ATF4 expression , 2014, Nucleic acids research.

[16]  M. Mann,et al.  Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells , 2014, Nature Methods.

[17]  R. Cencic,et al.  Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A , 2013, Blood Cancer Journal.

[18]  K. Shokat,et al.  Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers , 2013, Proceedings of the National Academy of Sciences.

[19]  R. Spriggs,et al.  Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation , 2013, Science.

[20]  R. Cencic,et al.  A cellular response linking eIF4AI activity to eIF4AII transcription. , 2012, RNA.

[21]  S. Lowe,et al.  Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis. , 2012, Cell reports.

[22]  R. Cencic,et al.  Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies. , 2012, Journal of medicinal chemistry.

[23]  J. Chiorini,et al.  Mechanisms of translational regulation by a human eIF5-mimic protein , 2011, Nucleic acids research.

[24]  Luis Carrasco,et al.  The Multifaceted Poliovirus 2A Protease: Regulation of Gene Expression by Picornavirus Proteases , 2011, Journal of biomedicine & biotechnology.

[25]  P. Pandolfi,et al.  eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression , 2010, Proceedings of the National Academy of Sciences.

[26]  M. Handel,et al.  Mutation of Eif4g3, encoding a eukaryotic translation initiation factor, causes male infertility and meiotic arrest of mouse spermatocytes , 2010, Development.

[27]  S. Formenti,et al.  Translational control in cancer , 2010, Nature Reviews Cancer.

[28]  Gerald C. Chu,et al.  Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. , 2009, Cancer cell.

[29]  R. Schneider,et al.  Inflammatory breast cancer cells are constitutively adapted to hypoxia , 2009, Cell cycle.

[30]  David E. Housman,et al.  mTORC1 promotes survival through translational control of Mcl-1 , 2008, Proceedings of the National Academy of Sciences.

[31]  R. Cencic,et al.  c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. , 2008, Cancer research.

[32]  S. Lowe,et al.  Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. , 2008, The Journal of clinical investigation.

[33]  S. Lowe,et al.  Dissecting eIF4E action in tumorigenesis. , 2007, Genes & development.

[34]  Tao Wang,et al.  Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. , 2007, The Journal of clinical investigation.

[35]  S. Nagata,et al.  Mnk2 and Mnk1 Are Essential for Constitutive and Inducible Phosphorylation of Eukaryotic Initiation Factor 4E but Not for Cell Growth or Development , 2004, Molecular and Cellular Biology.

[36]  Amy R. Cameron,et al.  Characterization of mammalian eIF4E-family members. , 2004, European journal of biochemistry.

[37]  S. Lowe,et al.  Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy , 2004, Nature.

[38]  N. Sonenberg,et al.  The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation , 2003, Molecular and Cellular Biology.

[39]  C. Proud,et al.  Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot‐and‐mouth disease virus 3C protease: identification of the eIF4AI cleavage site , 2001, FEBS letters.

[40]  N. Sonenberg,et al.  Poliovirus 2A Protease Induces Apoptotic Cell Death , 2000, Molecular and Cellular Biology.

[41]  N. Sonenberg,et al.  Eukaryotic Translation Initiation Factor 4E (eIF4E) Binding Site and the Middle One-Third of eIF4GI Constitute the Core Domain for Cap-Dependent Translation, and the C-Terminal One-Third Functions as a Modulatory Region , 2000, Molecular and Cellular Biology.

[42]  Jonathan A. Cooper,et al.  Phosphorylation of the Cap-Binding Protein Eukaryotic Translation Initiation Factor 4E by Protein Kinase Mnk1 In Vivo , 1999, Molecular and Cellular Biology.

[43]  A. Gingras,et al.  Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E , 1999, The EMBO journal.

[44]  T. Fukuchi-Shimogori,et al.  Malignant transformation by overproduction of translation initiation factor eIF4G. , 1997, Cancer research.

[45]  R. Duncan,et al.  Differential expression of the murine eukaryotic translation initiation factor isogenes eIF4A(I) and eIF4A(II) is dependent upon cellular growth status. , 1997, Archives of biochemistry and biophysics.

[46]  N. Sonenberg,et al.  The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A. , 1993, The Journal of biological chemistry.

[47]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[48]  H. Trachsel,et al.  The mouse protein synthesis initiation factor 4A gene family includes two related functional genes which are differentially expressed. , 1988, The EMBO journal.

[49]  J. Hershey,et al.  Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. , 1987, The Journal of biological chemistry.

[50]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.